Dnmt3atm1Rlvn
Targeted Allele Detail
|
|
| Symbol: |
Dnmt3atm1Rlvn |
| Name: |
DNA methyltransferase 3A; targeted mutation 1, Ross Levine |
| MGI ID: |
MGI:6113600 |
| Synonyms: |
Dnmt3aLSL-R878H, Dnmt3aR878H |
| Gene: |
Dnmt3a Location: Chr12:3856007-3964443 bp, + strand Genetic Position: Chr12, 1.99 cM, cytoband A2-A3
|
| Alliance: |
Dnmt3atm1Rlvn page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:241153
|
| Parent Cell Line: |
iTL IC1 (ES Cell)
|
| Strain of Origin: |
C57BL/6NTac
|
|
| Allele Type: |
|
Targeted (Conditional ready, Humanized sequence, No functional change) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: The targeting vector is designed to insert a minigene combining exons 23 and 24 in place of the endogenous exon 23. This minigene was modified to harbor a guanine to adenine substitution at amino acid 878, resulting in an arginine to histidine mutation (R878H), which corresponds to a R882H mutation commonly found in patients with acute myeloid leukemia (AML). A floxed STOP/neomycin cassette, including a splice acceptor and 3x SV40 polyA signals (saPGK-Neo-pA), was placed directly upstream of the modified minigene.
(J:241153)
|
|
|
|
|
| Original: |
J:241153 Guryanova OA, et al., DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nat Med. 2016 Dec;22(12):1488-1495 |
| All: |
8 reference(s) |
|